Cramer warns of ‘incredibly overconfident’ market after U.S.-Iran ceasefire
“The idea that everything will finally go right in the Middle East seems like a real stretch to me,” Cramer said.
Where fixed income investors are finding yield as geopolitical risk rattles markets
In the world of fixed income, being picky on credit quality and mindful of bond duration pays off.
Epstein files: House committee plans hearings with victims, Comer says
Post Content
Sam Altman’s house hit with Molotov cocktail, OpenAI San Francisco headquarters threatened
Police arrested a suspect at OpenAI’s headquarters for allegedly threatening arson after an attack on CEO Sam Altman’s home.
Vance, Bessent questioned tech giants on AI security before Anthropic’s Mythos release
Bessent and Fed Chair Jerome Powell separately met with the heads of the biggest U.S. banks to address the potential cyber threat of Anthropic’s Mythos.
Social Security 2027 cost-of-living adjustment estimate rises with gas prices
New government data shows the pace of inflation has increased, pushing up one estimate for the Social Security cost-of-living adjustment for 2027.
Earnings season could finally give the stock market some good news. Here’s what’s ahead
Given a strong earnings backdrop, investors have been optimistic that companies can weather an energy shock — so long as there is a quick resolution to the war.
Merck shares are forming a bullish chart pattern, and a breakout could be on the horizon
The pharmaceutical giant is a standout performer within the health-care sector, and the stock could be poised for a big jump.
Merck shares are forming a bullish chart pattern, and a breakout could be on the horizon
The pharmaceutical giant is a standout performer within the health-care sector, and the stock could be poised for a big jump.
Former Sen. Ben Sasse shines the spotlight on a possible breakthrough for pancreatic cancer
Former Sen. Ben Sasse is taking Revolution Medicines’ daraxonrasib, which has shown promise as a treatment for pancreatic cancer.